Management and Key Opinion Leader Mark Sulkowski from John Hopkins University School of Medicine will discuss the positive Phase 1b Data from ALG-000184 for treatment of CHB on a conference call to be held on July 18 at 3 pm. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGS:
- Aligos Therapeutics management to meet virtually with Piper Sandler
- Aligos Therapeutics to Host KOL Event to Discuss the Positive Phase 1b Data from ALG-000184 for the Treatment of CHB
- Aligos Therapeutics to host KOL event to discuss Phase 1b data of ALG-000184
- Aligos Therapeutics Shareholders Back Key Corporate Resolutions
- Aligos Therapeutics presents data from ALG-000184 at EASL